Host genetics and HIV-1: the final phase?


Autoria(s): Fellay, J; Shianna, KV; Telenti, A; Goldstein, DB
Data(s)

14/10/2010

Identificador

http://www.ncbi.nlm.nih.gov/pubmed/20976252

PLoS Pathog, 2010, 6 (10), pp. e1001033 - ?

http://hdl.handle.net/10161/4604

1553-7374

http://hdl.handle.net/10161/4604

Idioma(s)

ENG

en_US

Relação

PLoS Pathog

10.1371/journal.ppat.1001033

Plos Pathogens

Tipo

Journal Article

Cobertura

United States

Resumo

This is a crucial transition time for human genetics in general, and for HIV host genetics in particular. After years of equivocal results from candidate gene analyses, several genome-wide association studies have been published that looked at plasma viral load or disease progression. Results from other studies that used various large-scale approaches (siRNA screens, transcriptome or proteome analysis, comparative genomics) have also shed new light on retroviral pathogenesis. However, most of the inter-individual variability in response to HIV-1 infection remains to be explained: genome resequencing and systems biology approaches are now required to progress toward a better understanding of the complex interactions between HIV-1 and its human host.

Formato

e1001033 - ?

Palavras-Chave #Cohort Studies #Disease Progression #Genetic Variation #HIV Infections #HIV-1 #Host-Pathogen Interactions #Humans #Infection Control #Models, Biological #Treatment Outcome